Giulia C. Kennedy - 11 Nov 2022 Form 4 Insider Report for VERACYTE, INC. (VCYT)

Reporting relationship
Chief Scientific & Med Officer
Issuer ticker
VCYT
Reported as of
11 Nov 2022
Net transaction value
-$30
Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
15 Nov 2022, 16:02:02 UTC
Prior SEC filing
08 Nov 2022
Next SEC filing
06 Dec 2022
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Jonathan Wygant as attorney-in-fact

Key filing fact

Giulia C. Kennedy filed Form 4 for VERACYTE, INC. (VCYT) on 15 Nov 2022.

Key facts

  • This page summarizes Giulia C. Kennedy's Form 4 filing for VERACYTE, INC. (VCYT).
  • 3 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 15 Nov 2022, 16:02.

Change

  • Previous filing in this sequence was filed on 08 Nov 2022.
  • Current net transaction value: -$30.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

VCYT transaction

Common Stock

Options Exercise

Transaction value
$28.68
Shares
+2
Change %
+0%
Price
$14.34
Shares after
68,003
Date
11 Nov 2022
Ownership
Direct
Footnotes
F1
VCYT transaction

Common Stock

Sale

Transaction value
$58.68
Shares
-2
Change %
-0%
Price
$29.34
Shares after
68,001
Date
11 Nov 2022
Ownership
Direct
Footnotes
F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

VCYT transaction Derivative

Stock Option (right to buy)

Options Exercise

Transaction value
$0
Shares
-2
Change %
-100%
Price
$0.000000*
Shares after
0
Date
11 Nov 2022
Ownership
Direct
Underlying class
Common Stock
Underlying amount
2
Exercise price
$14.34
Footnotes
F1, F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on June 14, 2022.

Footnote F2

The option is fully vested.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .